$MRVL

Koopmans Chris sold $2.8M of MRVL (indirect holdings)

Koopmans Chris (President and COO) sold 10,000 indirectly-held shares of Marvell Technology, Inc. (MRVL) at $281.92 ($2.82M total) on 2026-07-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Koopmans Chris
Published Jul 1, 2026, 9:47 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 1, 2026, 9:48 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$MRVL
Neutral
medium confidence
Mentioned
$MRVL
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$MRVLNeutralLow
01

Why it matters

The disclosure updates the record of insider activity (open-market sale) but does not introduce new company fundamentals or guidance.

02

Market read

Traders may monitor for follow-on insider activity, but the 10b5-1 structure limits interpretive value.

03

What to watch

The filing notes indirect holdings and post-transaction share count, but provides no context on total insider exposure, other concurrent sales, or whether the plan size/timing is typical.

Relevance 5/10Novelty 5/10Timing: filed 2026-07-01 (after-hours) for an insider sale executed the same day

Background

This is an SEC Form 4 insider transaction disclosure for Marvell Technology, Inc. (MRVL).

Company-level read

Ticker impact

$MRVLNeutralMedium confidence
Context

Marvell’s President and COO Chris Koopmans sold 10,000 shares in an open-market transaction at $281.92 on 2026-07-01 under a 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move; any impact is likely brief and sentiment-driven.

Evidence & confidence

The filing is a Form 4 insider sale with a pre-arranged 10b5-1 plan, which typically reduces interpretive value versus discretionary selling. The article contains no new operational, financial, or regulatory catalyst.

Market effects

Minimal; this is company-specific insider transaction data with no disclosed sector-wide catalyst.

Minimal; no macro/regional linkage beyond general US equity sentiment.

Minimal; no international deal/regulatory development mentioned.

Counterpoint

Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may reflect scheduled liquidity rather than bearish expectations, so traders may ignore it for directional bias.

Key entities

  • Marvell Technology, Inc.

    Subject of the Form 4 insider transaction; President and COO sold shares under a 10b5-1 plan.

  • Koopmans Chris

    President and COO; executed an open-market sale of 10,000 shares at $281.92 on 2026-07-01.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$MRVLMedAI 8/10

AI stocks drop after hot inflation report bolsters bets for Fed rate hikes

Tech stocks, especially AI-related ones, fell sharply after a higher-than-expected inflation report increased expectations of Fed rate hikes. Marvell (MRVL) dropped 8.7%, Oracle (ORCL) sank 8.8%, and Dell (DELL) fell 11.3%. Semiconductor stocks also declined, with Nvidia (NVDA) down 3.2%. Concerns include higher borrowing costs and increased competition from Chinese chipmakers.

$MRVLMed

Marvell Stocks Fall 4.62% Although New AI Interconnect Chips Ent

Marvell Technology (MRVL) shares fell 4.62% to $256.31 on October 14 after unveiling new AI interconnect chips. The Alaska E and Alaska A chips offer 3.2Tbps and 1.6Tbps connectivity, respectively. The company's valuation is 106.68% above the GF Value estimate of $124.01, indicating high growth expectations. Investors await customer qualification and production orders.

$MRVLMed

SA analyst upgrades/downgrades: META, VTRS, MRVL, COKE

Analysts upgraded Marvell Technology (MRVL) to Buy citing AI demand and revenue growth projections of $70-90B by FY2031. Viatris (VTRS) was also upgraded due to a strategic acquisition. Coca-Cola Consolidated (COKE) and Meta Platforms (META) were downgraded due to valuation concerns and margin pressures.

$MRVLMed

Marvell Technology (MRVL) Receives Bullish Upgrade from Bank of

Marvell Technology (MRVL) received a bullish upgrade from Bank of America after its Analyst Day, with a raised price target of $400. The company is seen as well-positioned in the AI infrastructure sector, but GuruFocus classifies it as overvalued, trading at $275.28 vs. a GF Value™ of $123.15. Insider selling totaled $13.57M over the past three months. MRVL has a GF Score™ of 74/100, reflecting strong growth but valuation concerns.